Report Package: TCR-Based Antibody and T-Cell Immunotherapy

It has long, soft, and velvety white hair, a beautiful face and a perfect body. The cialis generika per nachnahme effects of prednisone, a glucocorticoid, on the human fetus have not been systematically researched. While the drug is safe, it should never be used as a substitute for consulting a doctor.

You can get a refund or replacement product if you do not like dapoxetine 60. By understanding and communicating with patients, your doctor il cialis è meglio del viagra Salto de Pirapora may be able to provide tailored, individualized care to help reduce the number of people suffering from this condition. Safepen can be purchased at any drugstore or supermarket.

More info about license types

Free of 19 % VAT (except in Germany and also in the European Union without valid intl. VAT no), delivery costs do not apply.

You can also order this product via email or fax, please download the Order Form

Publisher: La Merie Publishing
Format: PDF
Product Line: Full Report
Product Code: LMFR0027
Release Date: May of 2018
Loading...

T-Cell Receptor (TCR)-based therapeutic cells and recombinant antibodies or antibody fusion proteins have emerged as a new class of effective cancer therapeutics. Both treatment modalities have in common that they are directed to intracellular targets wich are estimated to be 3-4 times more frequent tn surface protein targets. However, these intracellular cancer targets are not accessible to traditional monoclonal antibody or chimeric antigen receptor (CAR) T-cell therapy. While TCR engineered T-cells exert their effector function via the cytotoxicity of T-cells, antibodies can act via their intrinsic effects (ADCC, CDC) or by enhancing them as antibody-drug conjugates or T-cell redirecting bispecific antibodies.

This report package includes two full reports covering TCR-based T-cell and recombinant antibody (fusion protein) immunotherapy of cancer.

The original reports were published in January and May 2018, respectively:

and

Detailed report descriptions, tables of contents and sample pages from the reports can be found on the respective product page.

Single User License:

This license allows for use of a report by one named person, explicitly confirmed at point of sale

Departmental License:

This license allows for use of a report by members of the same Dept within the same enterprise location or of the same international Project Group.

Site License:

This license allows for use of a report by an unlimited number of people within the same enterprise location.

Global Site License:

This license allows for use of a report by an unlimited number of people within the same enterprise worldwide.

Contacts

Custom Support & Sale:

Mon–Fri: 10:00 am –5:00 pm GMT+01